These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

3888 related items for PubMed ID: 6166758

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Treatment of renal cell carcinoma with renal infarction, delayed nephrectomy, medroxyprogesterone, and xenogeneic immune RNA.
    Weigel JW, Mebust WK, Foret JD, Noble MJ, Votapka T, Krishnan EC, Jewell WR.
    Urology; 1985 Feb; 25(2):103-5. PubMed ID: 3969752
    [Abstract] [Full Text] [Related]

  • 23. Mediation of cytotoxic immune responses against human tumor-associated antigens by allogeneic immune RNA.
    Kern DH, Fritze D, Schick PM, Chow N, Pilch YH.
    J Natl Cancer Inst; 1976 Jul; 57(1):105-9. PubMed ID: 1003493
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Lymphocyte-mediated cytotoxicity in patients with renal and transitional cell carcinoma receiving BCG.
    Lange PH.
    Natl Cancer Inst Monogr; 1978 Dec; (49):343-5. PubMed ID: 748791
    [Abstract] [Full Text] [Related]

  • 27. Lysis of autologous tumor cells by peripheral blood lymphocytes treated with interleukin 2 in patients with renal cell carcinoma.
    Nakano E, Tada Y, Ichikawa Y, Fujioka H, Matsuda M, Takaha M, Sonoda T.
    J Urol; 1987 Apr; 137(4):641-8. PubMed ID: 3494137
    [Abstract] [Full Text] [Related]

  • 28. A randomized phase II trial comparing two different sequence combinations of autologous vaccine and human recombinant interferon gamma and human recombinant interferon alpha2B therapy in patients with metastatic renal cell carcinoma: clinical outcome and analysis of immunological parameters.
    Schwaab T, Heaney JA, Schned AR, Harris RD, Cole BF, Noelle RJ, Phillips DM, Stempkowski L, Ernstoff MS.
    J Urol; 2000 Apr; 163(4):1322-7. PubMed ID: 10737537
    [Abstract] [Full Text] [Related]

  • 29. Allogeneic hematopoietic cell transplantation for metastatic renal cell carcinoma after nonmyeloablative conditioning: toxicity, clinical response, and immunological response to minor histocompatibility antigens.
    Tykodi SS, Warren EH, Thompson JA, Riddell SR, Childs RW, Otterud BE, Leppert MF, Storb R, Sandmaier BM.
    Clin Cancer Res; 2004 Dec 01; 10(23):7799-811. PubMed ID: 15585611
    [Abstract] [Full Text] [Related]

  • 30. Cytotoxic activity of peripheral blood lymphocytes grown with interleukin 2 against autologous cultured tumor cells in patients with renal cell carcinoma: preliminary report.
    Nakano E, Tada Y, Ichikawa Y, Fujioka H, Ishibasi M, Matsuda M, Takaha M, Sonoda T.
    J Urol; 1985 Jul 01; 134(1):24-8. PubMed ID: 3925165
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Immunogenic RNA in the immunotherapy of cancer: the transfer of antitumor cytotoxic activity and tuberculin sensitivity to human lymphocytes using xenogeneic ribonucleic acid.
    Dodd MC, Scheetz ME, Rossio JL.
    Ann N Y Acad Sci; 1973 May 31; 207():454-67. PubMed ID: 4517721
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Immunotherapy with cytokine-induced killer cells in metastatic renal cell carcinoma.
    Su X, Zhang L, Jin L, Ye J, Guan Z, Chen R, Guo T.
    Cancer Biother Radiopharm; 2010 Aug 31; 25(4):465-70. PubMed ID: 20701541
    [Abstract] [Full Text] [Related]

  • 38. Immunologic evaluation of human renal cell carcinoma. In vitro studies.
    Elhilali MM, Nayak SK.
    Invest Urol; 1975 Jul 31; 13(1):60-6. PubMed ID: 49333
    [Abstract] [Full Text] [Related]

  • 39. Production and characterization of xenogeneic antisera to a human renal cell carcinoma-associated antigen.
    Ghose T, Belitsky P, Tai J, Janigan DT.
    J Natl Cancer Inst; 1979 Aug 31; 63(2):301-8. PubMed ID: 88535
    [Abstract] [Full Text] [Related]

  • 40. Immune cytolysis of human tumor cells mediated by xenogeneic "immune" RNA.
    Veltman LL, Kern DH, Pilch YH.
    Cell Immunol; 1974 Sep 31; 13(3):367-77. PubMed ID: 4476236
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 195.